| Model Number |
WNDPRV |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Necrosis (1971)
|
| Date of Event |
07/12/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Based on information provided, it cannot be determined that the alleged necrosis is related to prevena customizable¿ dressing.Device labeling, available in print states: the prevena customizable¿ dressing can be used for the following wound types: linear incisions.Non-linear incisions.Intersecting incisions.Dressing changes: dressing changes should occur every 24-72 hours, or more frequently based on a continuing evaluation of wound condition and patient presentation.Consider more frequent dressing changes in the presence of infection or abdominal contamination.The prevena¿ incision management system should not be used to treat open or dehisced surgical wounds or on patients who have excessive amounts of exudate from the incision area which may exceed the prevena¿ 45ml canister.The prevena¿ incision management system should be used with caution in the following patients: patients with fragile skin surrounding the incision as they may experience skin or tissue damage upon removal of the prevena¿ incision dressing.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2019, the following information was reported to kci by the plastic surgeon: on (b)(6) 2019, the patient with invasive carcinoma in the right breast underwent a bilateral mastectomy with placement of breast implants.The prevena customizable¿ dressing was applied to the patient's areolar incisions.On (b)(6) 2019, upon dressing removal, the plastic surgeon allegedly observed bilateral necrotic of the areola papillary complex noted as blackened aspects of the areolas.The plastic surgeon subsequently inserted a needle into the patient's areolas and there were no signs of bleeding.The plastic surgeon requested the patient place an adaptic¿ dressing on the wounds at home.On (b)(6) 2019, the plastic surgeon reported that on (b)(6) 2019, the areola papillary complex became necrotic, and the patient's areolas were surgically removed.The plastic surgeon associated the occurrence of the event to the use of the prevena customizable¿ dressing.A device history review of prevena customizable¿ dressing lot number 5433878 determined that all end release testing of product and packaging met specifications.The prevena customizable¿ dressing was discarded and the product was not returned, therefore a device evaluation could not be performed.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2019 upon dressing removal, the plastic surgeon allegedly observed bilateral necrotic of the areola papillary complex noted as blackened aspects of the areolas.The plastic surgeon subsequently inserted a needle into the patient's areolas and bleeding was observed demonstraing hope of recovering areolas.
|
| |
|
Additional Manufacturer Narrative
|
|
Mdr-3009897021-2019-00126_109431-iss sent on 09-aug-2019 stated the following: on (b)(6) 2019 upon dressing removal, the plastic surgeon allegedly observed bilateral necrotic of the areola papillary complex noted as blackened aspects of the areolas.The plastic surgeon subsequently inserted a needle into the patient's areolas and there were no signs of bleeding.Correction: on (b)(6) 2019, upon dressing removal, the plastic surgeon allegedly observed bilateral necrotic of the areola papillary complex noted as blackened aspects of the areolas.The plastic surgeon subsequently inserted a needle into the patient's areolas and bleeding was observed demonstraing hope of recovering areolas.
|
| |
|
Search Alerts/Recalls
|